By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Kineta Inc. 

307 Westlake Ave North
Suite 200
Seattle  Washington  98109  U.S.A.
Phone: 206-378-0400 Fax: 206-378-0408


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Kineta, Seattle Children's Research Institute Present New Data Demonstrating Positive, Predictive Responses To Dalazatide In Lupus 11/10/2015 12:36:01 PM
Kineta Presents New Data Demonstrating Positive, Predictive Responses To Dalazatide In Psoriasis Patients And In Lupus, ANCA Vasculitis Studies At American College of Rheumatology Annual Meeting 11/9/2015 1:10:34 PM
Kineta To Present Updated Dalazatide Clinical Results, And Dalazatide Lupus Research At American College of Rheumatology Annual Meeting 10/26/2015 12:44:52 PM
Kineta To Give Update On Dalazatide Clinical Trial Results At BIO International Meeting 6/9/2015 12:09:37 PM
Kineta Expands Seattle Footprint With New Office Space 5/14/2015 6:13:25 AM
Kineta Inc. Announces Promising Top-Line Clinical Results For Dalazatide; Target Implicated In Broad Array Of Autoimmune Diseases 5/5/2015 8:56:46 AM
Kineta Inc., University of Groningen Present New, Positive Data For Dalazatide In ANCA Vasculitis, An Orphan Disease 4/21/2015 11:41:05 AM
Kineta Inc.’s Adjuvants Boost Flu Vaccine Effectiveness In Data Presented At World Vaccine Congress 4/9/2015 10:49:15 AM
Kineta Inc.’s Novel Antiviral Compounds Inhibit Broad Array Of Emerging And Current Viruses Including Ebola 3/26/2015 9:06:22 AM
Kineta Inc.’s SHK-186 Shows Encouraging Early Results As Potential Therapy For Autoimmune Eye Diseases 3/19/2015 10:23:49 AM
1234
//-->